Abstract
We evaluated the in vitro activities of clinafloxacin, CL331,002, LY333328, quinupristin dalfopristin, and eperezolid (formerly known as U-100,592) against four strains of enterococci. All regimens tested resulted in the growth inhibition of each isolate. Against the three clinafloxacin-susceptible strains, clinafloxacin tested alone was the most active treatment, decreasing the bacterial inoculum by more than 3 log10 CFU/ml after 24 h in time-kill curve studies.
Full Text
The Full Text of this article is available as a PDF (137.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arthur M., Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother. 1993 Aug;37(8):1563–1571. doi: 10.1128/aac.37.8.1563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burney S., Landman D., Quale J. M. Activity of clinafloxacin against multidrug-resistant Enterococcus faecium. Antimicrob Agents Chemother. 1994 Jul;38(7):1668–1670. doi: 10.1128/aac.38.7.1668. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bush L. M., Calmon J., Cherney C. L., Wendeler M., Pitsakis P., Poupard J., Levison M. E., Johnson C. C. High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections. Ann Intern Med. 1989 Apr 1;110(7):515–520. doi: 10.7326/0003-4819-110-7-515. [DOI] [PubMed] [Google Scholar]
- Caron F., Pestel M., Kitzis M. D., Lemeland J. F., Humbert G., Gutmann L. Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium. J Infect Dis. 1995 Jan;171(1):106–112. doi: 10.1093/infdis/171.1.106. [DOI] [PubMed] [Google Scholar]
- Emori T. G., Gaynes R. P. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev. 1993 Oct;6(4):428–442. doi: 10.1128/cmr.6.4.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fraise A. P., Brenwald N., Andrews J. M., Wise R. In-vitro activity of two glycylcyclines against enterococci resistant to other agents. J Antimicrob Chemother. 1995 Jun;35(6):877–881. doi: 10.1093/jac/35.6.877. [DOI] [PubMed] [Google Scholar]
- Kaatz G. W., Seo S. M., Lamp K. C., Bailey E. M., Rybak M. J. CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother. 1992 Jun;36(6):1192–1197. doi: 10.1128/aac.36.6.1192. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kang S. L., Rybak M. J. Comparative in vitro activities of LY191145, a new glycopeptide, and vancomycin against Staphylococcus aureus and Staphylococcus-infected fibrin clots. Antimicrob Agents Chemother. 1995 Dec;39(12):2832–2834. doi: 10.1128/aac.39.12.2832. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moellering R. C., Jr The Garrod Lecture. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. J Antimicrob Chemother. 1991 Jul;28(1):1–12. doi: 10.1093/jac/28.1.1. [DOI] [PubMed] [Google Scholar]
- Nachamkin I., Axelrod P., Talbot G. H., Fischer S. H., Wennersten C. B., Moellering R. C., Jr, MacGregor R. R. Multiply high-level-aminoglycoside-resistant enterococci isolated from patients in a university hospital. J Clin Microbiol. 1988 Jul;26(7):1287–1291. doi: 10.1128/jcm.26.7.1287-1291.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Norrby S. R., Jonsson M. Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivative. Antimicrob Agents Chemother. 1988 Aug;32(8):1278–1281. doi: 10.1128/aac.32.8.1278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Quintiliani R., Jr, Evers S., Courvalin P. The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci. J Infect Dis. 1993 May;167(5):1220–1223. doi: 10.1093/infdis/167.5.1220. [DOI] [PubMed] [Google Scholar]
- Shlaes D. M., Bouvet A., Devine C., Shlaes J. H., al-Obeid S., Williamson R. Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256. Antimicrob Agents Chemother. 1989 Feb;33(2):198–203. doi: 10.1128/aac.33.2.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tack K. J., McGuire N. M., Eiseman I. A. Initial clinical experience with clinafloxacin in the treatment of serious infections. Drugs. 1995;49 (Suppl 2):488–491. doi: 10.2165/00003495-199500492-00145. [DOI] [PubMed] [Google Scholar]